The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022–2032.
Biomarkers, or biological indicators, have revolutionized the fields of medicine...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian